Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

FDA recently announced these approvals: Novartis' Tasigna<SUP>&reg;</SUP> (nilotinib) capsules has been approved by FDA for treating Philadelphia chromosome positive chronic myeloid leukemia in adults.

Drug Criteria & Outcomes: New FDA Approvals